Parameter
| Biomarker | Streptococcus | Full name | Streptococcus spp. | Molecular Type | Microbes |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Diagnosis, Prognosis | ||
| Disease | Esophageal Carcinoma | Disease Subtypes | / | ||
| Organ | Esophagus | Test Sample / Technology Platform | Esophageal tissue/stool (16S rRNA sequencing, qPCR) | ||
| Pathobiological Mechanisms | Abnormal abundance is related to the occurrence of ESCC, and the high expression of some subtypes is related to the poor prognosis of patients, which is involved in the regulation of inflammatory response in tumor microenvironment | ||||
| Clinical Availability Status | Clinical phase: As a key marker in the gut and esophageal microbiota, it has been validated in multiple cohorts | ||||
| Notes and Dynamics | It can be used as an auxiliary marker for non-invasive diagnosis, and its synergistic effect with other microorganisms deserves further study | ||||